Home › Funds › Osmosis Investment Management UK Ltd › GILD

Osmosis Investment Management UK Ltd position in GILD

GILEAD SCIENCES INC · Health Care

Osmosis Investment Management UK Ltd reported holding 93,008 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$13.9M, representing 0.62% of its reported portfolio and ranking #27 among its reported holdings. Osmosis Investment Management UK Ltd has disclosed GILD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)93.01K sh
Reported value held$13.86M
Portfolio Weight0.62%
First reportedQ4 2025
Last changeAdd
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Osmosis Investment Management UK Ltd's GILD position evolved

Osmosis Investment Management UK Ltd first disclosed a stake in GILD in Q4 2025 at 90,343 shares (US$11.1M). The position peaked in Q1 2026 at 173,584 shares, worth US$24.2M. Across 4 filings, Osmosis Investment Management UK Ltd increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 93,008 shares valued at US$13.9M — an increase of 2,697 shares quarter over quarter.. Notable position changes include a 92% increase in Q1 2026 (shares fell 10% over the following quarter), a 48% trim in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 90.34K $11.09M New
Q1 2026 173.58K $24.19M Add
Q2 2026 90.31K $11.41M Reduce
Q3 2026 93.01K $13.86M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Osmosis Investment Management UK Ltd held GILD?

Osmosis Investment Management UK Ltd has disclosed GILD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Osmosis Investment Management UK Ltd's current position in GILD?

As of Q3 2026, Osmosis Investment Management UK Ltd holds 93.01K shares of GILD (GILEAD SCIENCES INC), valued at $13.86M, representing 0.62% of its reported portfolio and ranking #27.

Has Osmosis Investment Management UK Ltd been buying or selling GILD?

In the latest 13F filing (Q3 2026), Osmosis Investment Management UK Ltd increased its position in GILD. The position peaked in Q1 2026 at 173.58K shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.